Tatva Chintan Pharma Chem Limited (NSE:TATVA)
India · Delayed Price · Currency is INR 1,194.00
-2.20 (-0.18%)
Jun 19, 2026, 3:30 PM IST
Tatva Chintan Pharma Chem Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Tatva Chintan Pharma Chem stock has a consensus rating of "Hold" and an average price target of ₹1,390. The average 1-year stock price forecast is 16.42% higher than the current stock price, while the lowest is ₹835.00 (-30.07%) and the highest is ₹1,955 (+63.74%).
Price Target: ₹1,390 (+16.42%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Tatva Chintan Pharma Chem stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Jan '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Strong Sell | 2 | 2 | 1 | 1 | 1 | 1 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Financial Forecast
Revenue This Year
6.25B
from 5.06B
Increased by 23.45%
Revenue Next Year
7.58B
from 6.25B
Increased by 21.30%
EPS This Year
26.50
from 17.98
Increased by 47.39%
EPS Next Year
38.40
from 26.50
Increased by 44.91%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 6.4B | ||
| Avg | 6.2B | ||
| Low | 6.1B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 26.1% | ||
| Avg | 23.5% | ||
| Low | 20.8% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | - | ||
| Avg | 26.50 | ||
| Low | - |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | - | ||
| Avg | 47.4% | ||
| Low | - |